Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05815784 · ClinicalTrials.gov registry record · Phase 2
Myopia Control: a Comparison Study Between Atropine and MiSight
A Phase 2 study of Myopia, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 348
- Enrollment target
- 1
- Study location
NCT05815784 is a Phase 2 study of Myopia that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 348 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (32% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05815784, a Phase 2 study of Myopia, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 348 participants
- Enrollment target
- 1
- Study location
Study Summary
This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.
Conditions Studied
Interventions
- DRUG Atropine
- DEVICE MiSight contact lenses
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2026-03-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05815784
The ClinicalTrials.gov registry entry for NCT05815784 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 348 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (32% higher). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Atropine is the first listed.
NCT05815784 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05815784 about?
NCT05815784 is a clinical study titled "Myopia Control: a Comparison Study Between Atropine and MiSight". This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best pract...
What is the current status of trial NCT05815784?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 348 participants. The study started on 2023-05-02. Estimated completion is 2026-03-13.
What conditions does trial NCT05815784 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05815784?
The interventions under investigation include: Atropine (DRUG), MiSight contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05815784?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05815784 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control
COMPLETED · Phase 2
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.